![Quiver Logo](/static/img/logo-icon.png)
![SRZN logo](https://quiver-logos.s3.us-east-2.amazonaws.com/srzn.png)
Surrozen, Inc. Common
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view SRZN Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.
Recent trades of SRZN by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by SRZN's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Recent insights relating to SRZN
Recent picks made for SRZN stock on CNBC
ETFs with the largest estimated holdings in SRZN
Flights by private jets registered to SRZN
![Quiver Logo](/static/img/logo-icon.png)